Organ Transplantation Immunosuppressive Drug Market - Global Outlook and Forecast 2022-2028

January 2022 | 66 pages | ID: OAA962F62DC6EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Organ Transplantation Immunosuppressive Drug in Global, including the following market information:

Global Organ Transplantation Immunosuppressive Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Organ Transplantation Immunosuppressive Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Calcineurin Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Organ Transplantation Immunosuppressive Drug include AbbVie, Allergan Plc, Astellas Pharma, Bristol-Myers Squibb Company, Roche, GlaxoSmithKline plc, Novartis AG, Pfizer and Sanofi S.A. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Organ Transplantation Immunosuppressive Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Organ Transplantation Immunosuppressive Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Organ Transplantation Immunosuppressive Drug Market Segment Percentages, by Type, 2021 (%)

• Calcineurin Inhibitors
• Antiproliferative Agents
• mTOR Inhibitors
• Antibodies
• Steroids

Global Organ Transplantation Immunosuppressive Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Organ Transplantation Immunosuppressive Drug Market Segment Percentages, by Application, 2021 (%)

• Kidney Transplant
• Bone Marrow Transplant
• Liver Transplant
• Heart Transplant
• Lungs Transplant
• Others Transplant

Global Organ Transplantation Immunosuppressive Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Organ Transplantation Immunosuppressive Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Organ Transplantation Immunosuppressive Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Organ Transplantation Immunosuppressive Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Allergan Plc
• Astellas Pharma
• Bristol-Myers Squibb Company
• Roche
• GlaxoSmithKline plc
• Novartis AG
• Pfizer
• Sanofi S.A.
• Veloxis Pharmaceuticals A/S

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Organ Transplantation Immunosuppressive Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Organ Transplantation Immunosuppressive Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ORGAN TRANSPLANTATION IMMUNOSUPPRESSIVE DRUG OVERALL MARKET SIZE

2.1 Global Organ Transplantation Immunosuppressive Drug Market Size: 2021 VS 2028
2.2 Global Organ Transplantation Immunosuppressive Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Organ Transplantation Immunosuppressive Drug Players in Global Market
3.2 Top Global Organ Transplantation Immunosuppressive Drug Companies Ranked by Revenue
3.3 Global Organ Transplantation Immunosuppressive Drug Revenue by Companies
3.4 Top 3 and Top 5 Organ Transplantation Immunosuppressive Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Organ Transplantation Immunosuppressive Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Organ Transplantation Immunosuppressive Drug Players in Global Market
  3.6.1 List of Global Tier 1 Organ Transplantation Immunosuppressive Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Organ Transplantation Immunosuppressive Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Organ Transplantation Immunosuppressive Drug Market Size Markets, 2021 & 2028
  4.1.2 Calcineurin Inhibitors
  4.1.3 Antiproliferative Agents
  4.1.4 mTOR Inhibitors
  4.1.5 Antibodies
  4.1.6 Steroids
4.2 By Type - Global Organ Transplantation Immunosuppressive Drug Revenue & Forecasts
  4.2.1 By Type - Global Organ Transplantation Immunosuppressive Drug Revenue, 2017-2022
  4.2.2 By Type - Global Organ Transplantation Immunosuppressive Drug Revenue, 2023-2028
  4.2.3 By Type - Global Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Organ Transplantation Immunosuppressive Drug Market Size, 2021 & 2028
  5.1.2 Kidney Transplant
  5.1.3 Bone Marrow Transplant
  5.1.4 Liver Transplant
  5.1.5 Heart Transplant
  5.1.6 Lungs Transplant
  5.1.7 Others Transplant
5.2 By Application - Global Organ Transplantation Immunosuppressive Drug Revenue & Forecasts
  5.2.1 By Application - Global Organ Transplantation Immunosuppressive Drug Revenue, 2017-2022
  5.2.2 By Application - Global Organ Transplantation Immunosuppressive Drug Revenue, 2023-2028
  5.2.3 By Application - Global Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Organ Transplantation Immunosuppressive Drug Market Size, 2021 & 2028
6.2 By Region - Global Organ Transplantation Immunosuppressive Drug Revenue & Forecasts
  6.2.1 By Region - Global Organ Transplantation Immunosuppressive Drug Revenue, 2017-2022
  6.2.2 By Region - Global Organ Transplantation Immunosuppressive Drug Revenue, 2023-2028
  6.2.3 By Region - Global Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Organ Transplantation Immunosuppressive Drug Revenue, 2017-2028
  6.3.2 US Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.3.3 Canada Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.3.4 Mexico Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Organ Transplantation Immunosuppressive Drug Revenue, 2017-2028
  6.4.2 Germany Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.4.3 France Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.4.4 U.K. Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.4.5 Italy Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.4.6 Russia Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.4.8 Benelux Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Organ Transplantation Immunosuppressive Drug Revenue, 2017-2028
  6.5.2 China Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.5.3 Japan Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.5.4 South Korea Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.5.6 India Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Organ Transplantation Immunosuppressive Drug Revenue, 2017-2028
  6.6.2 Brazil Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.6.3 Argentina Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue, 2017-2028
  6.7.2 Turkey Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.7.3 Israel Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028
  6.7.5 UAE Organ Transplantation Immunosuppressive Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Organ Transplantation Immunosuppressive Drug Major Product Offerings
  7.1.4 AbbVie Organ Transplantation Immunosuppressive Drug Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Allergan Plc
  7.2.1 Allergan Plc Corporate Summary
  7.2.2 Allergan Plc Business Overview
  7.2.3 Allergan Plc Organ Transplantation Immunosuppressive Drug Major Product Offerings
  7.2.4 Allergan Plc Organ Transplantation Immunosuppressive Drug Revenue in Global Market (2017-2022)
  7.2.5 Allergan Plc Key News
7.3 Astellas Pharma
  7.3.1 Astellas Pharma Corporate Summary
  7.3.2 Astellas Pharma Business Overview
  7.3.3 Astellas Pharma Organ Transplantation Immunosuppressive Drug Major Product Offerings
  7.3.4 Astellas Pharma Organ Transplantation Immunosuppressive Drug Revenue in Global Market (2017-2022)
  7.3.5 Astellas Pharma Key News
7.4 Bristol-Myers Squibb Company
  7.4.1 Bristol-Myers Squibb Company Corporate Summary
  7.4.2 Bristol-Myers Squibb Company Business Overview
  7.4.3 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Major Product Offerings
  7.4.4 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Company Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Organ Transplantation Immunosuppressive Drug Major Product Offerings
  7.5.4 Roche Organ Transplantation Immunosuppressive Drug Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 GlaxoSmithKline plc
  7.6.1 GlaxoSmithKline plc Corporate Summary
  7.6.2 GlaxoSmithKline plc Business Overview
  7.6.3 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Major Product Offerings
  7.6.4 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline plc Key News
7.7 Novartis AG
  7.7.1 Novartis AG Corporate Summary
  7.7.2 Novartis AG Business Overview
  7.7.3 Novartis AG Organ Transplantation Immunosuppressive Drug Major Product Offerings
  7.7.4 Novartis AG Organ Transplantation Immunosuppressive Drug Revenue in Global Market (2017-2022)
  7.7.5 Novartis AG Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Organ Transplantation Immunosuppressive Drug Major Product Offerings
  7.8.4 Pfizer Organ Transplantation Immunosuppressive Drug Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Sanofi S.A.
  7.9.1 Sanofi S.A. Corporate Summary
  7.9.2 Sanofi S.A. Business Overview
  7.9.3 Sanofi S.A. Organ Transplantation Immunosuppressive Drug Major Product Offerings
  7.9.4 Sanofi S.A. Organ Transplantation Immunosuppressive Drug Revenue in Global Market (2017-2022)
  7.9.5 Sanofi S.A. Key News
7.10 Veloxis Pharmaceuticals A/S
  7.10.1 Veloxis Pharmaceuticals A/S Corporate Summary
  7.10.2 Veloxis Pharmaceuticals A/S Business Overview
  7.10.3 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Major Product Offerings
  7.10.4 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Revenue in Global Market (2017-2022)
  7.10.5 Veloxis Pharmaceuticals A/S Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Organ Transplantation Immunosuppressive Drug Market Opportunities & Trends in Global Market
Table 2. Organ Transplantation Immunosuppressive Drug Market Drivers in Global Market
Table 3. Organ Transplantation Immunosuppressive Drug Market Restraints in Global Market
Table 4. Key Players of Organ Transplantation Immunosuppressive Drug in Global Market
Table 5. Top Organ Transplantation Immunosuppressive Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Organ Transplantation Immunosuppressive Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Organ Transplantation Immunosuppressive Drug Product Type
Table 9. List of Global Tier 1 Organ Transplantation Immunosuppressive Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Organ Transplantation Immunosuppressive Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Organ Transplantation Immunosuppressive Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Organ Transplantation Immunosuppressive Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Organ Transplantation Immunosuppressive Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Organ Transplantation Immunosuppressive Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Organ Transplantation Immunosuppressive Drug Product Offerings
Table 32. AbbVie Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Plc Corporate Summary
Table 34. Allergan Plc Organ Transplantation Immunosuppressive Drug Product Offerings
Table 35. Allergan Plc Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), (2017-2022)
Table 36. Astellas Pharma Corporate Summary
Table 37. Astellas Pharma Organ Transplantation Immunosuppressive Drug Product Offerings
Table 38. Astellas Pharma Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Company Corporate Summary
Table 40. Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Product Offerings
Table 41. Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Organ Transplantation Immunosuppressive Drug Product Offerings
Table 44. Roche Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline plc Corporate Summary
Table 46. GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Product Offerings
Table 47. GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), (2017-2022)
Table 48. Novartis AG Corporate Summary
Table 49. Novartis AG Organ Transplantation Immunosuppressive Drug Product Offerings
Table 50. Novartis AG Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Organ Transplantation Immunosuppressive Drug Product Offerings
Table 53. Pfizer Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), (2017-2022)
Table 54. Sanofi S.A. Corporate Summary
Table 55. Sanofi S.A. Organ Transplantation Immunosuppressive Drug Product Offerings
Table 56. Sanofi S.A. Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), (2017-2022)
Table 57. Veloxis Pharmaceuticals A/S Corporate Summary
Table 58. Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Product Offerings
Table 59. Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Organ Transplantation Immunosuppressive Drug Segment by Type in 2021
Figure 2. Organ Transplantation Immunosuppressive Drug Segment by Application in 2021
Figure 3. Global Organ Transplantation Immunosuppressive Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Organ Transplantation Immunosuppressive Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Organ Transplantation Immunosuppressive Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Organ Transplantation Immunosuppressive Drug Revenue in 2021
Figure 8. By Type - Global Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028
Figure 12. US Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028
Figure 16. Germany Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028
Figure 24. China Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Organ Transplantation Immunosuppressive Drug Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Organ Transplantation Immunosuppressive Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Plc Organ Transplantation Immunosuppressive Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Astellas Pharma Organ Transplantation Immunosuppressive Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Organ Transplantation Immunosuppressive Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis AG Organ Transplantation Immunosuppressive Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Organ Transplantation Immunosuppressive Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sanofi S.A. Organ Transplantation Immunosuppressive Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)